CAMBRIDGE, Mass.--()--MC10 Inc. today announced it has closed on a $2 million investment from Aberdare Ventures and added managing partner, Paul Klingenstein, to its board of directors. Based in San Francisco, Aberdare Ventures invests in companies that are transforming healthcare, and its investment in MC10 underscores the company’s unique opportunity to reshape electronics in the healthcare industry.
“We love this team and their technology”
MC10 takes high-performance electronics ‘out-of-the-box’ and into new products that blur the lines between user and device. The company is developing a variety of products including interventional circuits that can diagnose and influence tissue function and ‘seamless sensing’ devices that can monitor key aspects of performance such as the heart (ECG), the brain (EEG), muscles (EMG), body temperature, and hydration.
“After meeting the Aberdare team it became extremely clear that the firm is immersed in the markets MC10 is pursuing and that their input will add significant value to our efforts,” said David Icke, CEO of MC10 Inc. “Paul and the team at Aberdare share our belief that the convergence of technology and healthcare holds tremendous value and MC10’s approach in this space is a game changer.”
Aberdare Ventures invests in visionary entrepreneurs and technologies that are transforming healthcare around the world. Representative past Aberdare investments include Pharmion, Ironwood Pharmaceuticals, and Ablation Frontiers. Aberdare’s current portfolio includes leading companies at the convergence of efficient healthcare and next generation technologies such as Clovis Pharmaceuticals, Aviir, Sonitus Medical, Jiff, goBalto, and Rock Health.
“We love this team and their technology,” said Paul Klingenstein, managing partner at Aberdare Ventures. “Stretchable and conformable integrated circuits have the potential to transform healthcare, and likely other fields as well. This investment is perfectly consistent with the Aberdare strategy: to support leading technologies that can make healthcare more efficient and less costly.”
About Aberdare Ventures
Formed in 1999, Aberdare Ventures is a San Francisco-based venture capital firm investing in healthcare innovation, often at the earliest stages. Aberdare sees significant opportunity where new biological, engineering, and information technologies can address significant inefficiencies in global healthcare. Seven investment professionals oversee a committed capital base in excess of $400 million in aggregate. The firm has attracted and partnered with many superior entrepreneurial teams in its twelve plus years, repeatedly participating in growth from start-up to values exceeding $1 billion.
About MC10
MC10 takes electronics ‘out of the box’ to create thin, conformal systems that are able to move with the natural world. The company combines breakthrough technology with innovative engineering to develop exciting new consumer, medical, and industrial products. MC10 is headquartered in Cambridge, MA. Visit MC10 online at www.mc10inc.com.
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
Email 
